Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Edscharp who wrote (16198)	2/25/2003 7:23:11 AM
From: Robert K.	Read Replies (1) \| Respond to of 17367

Ed, I agree with everything you just said. Why am I optimistic on bpi. Well, development wise I am about as pissed off as possible. On the "potential" side, bpi works in vivo. IMO you would be dead without it. Or alternately you might have CF, arthritis, or some other maiming condition without it. IMO. Proving that bpi-21 works to fda satisfaction is another matter. The immune system is complex, bpi is not the only player and figuring out how to use correctly use bpi is like giving a nuKlear device to a neanderthaL AND TELLING HIM IN ENGLISH TO LET IT RIP. IMO will they figure out how to use bpi, yes. Will it be useful, very much so. Will xoma earn any benefit ???????? IMO bpi is a no-brainer, when we get the brains to use it> that I cant say. We have entrusted bpi-21 to baxter. They throughly unimpress me so far. Xoma for their part hasnt exactly pushed to hard, have they. Yes, I dream someday, somebody with some brainpower will wakeup and have the ability to do something here. That is my eternal hope. Standard K dislaimers, all IMO, no facts, and i know how to spell nukleer, I just dont want to get bitten by karnevor.